Atom | Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)

Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.

Summary: Supports U.S.-focused epidemiologic research on novel and emerging risk factors, and their interplay with established factors, in liver cancer development.

Key Information: Clinical trials are not allowed; applications focused solely on viral hepatitis or cohort infrastructure are non-responsive.

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing